Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
32,982,385
-
Number of holders
-
317
-
Total 13F shares, excl. options
-
30,205,611
-
Shares change
-
+965,805
-
Total reported value, excl. options
-
$5,201,601,524
-
Value change
-
+$176,038,628
-
Put/Call ratio
-
88%
-
Number of buys
-
182
-
Number of sells
-
-140
-
Price
-
$172.29
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q1 2022
389 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q1 2022.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 317 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,205,611 shares
of 32,982,385 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,896,785 shares), VANGUARD GROUP INC (3,050,162 shares), WELLINGTON MANAGEMENT GROUP LLP (1,875,274 shares), RIVERBRIDGE PARTNERS LLC (1,693,656 shares), AMERIPRISE FINANCIAL INC (1,518,776 shares), JPMORGAN CHASE & CO (1,384,041 shares), MACKENZIE FINANCIAL CORP (956,780 shares), PRICE T ROWE ASSOCIATES INC /MD/ (914,680 shares), STATE STREET CORP (871,346 shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (720,310 shares).
This table shows the top 317 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.